Axxam is an innovative Partner Research Organization (iPRO). We are a leading provider of integrated discovery services across Life Sciences industries including: pharmaceuticals, crop protection, animal health, cosmetics, fragrances, food and beverages. We have consolidated expertise across a broad range of discovery disciplines and innovative technologies including: assay development, high-throughput screening of both the Axxam high quality compound collections (synthetic and natural)  or those provided by our clients, compound management, hit identification and hit validation. Our performance-driven approach has been recognized by our clients as key to the success for their discovery programs. Axxam is also engaged in alliance-based research towards innovative small molecule therapies for diseases with a high unmet medical need. Axxam’s business terms are flexible, ranging from fee-for-service to risk-sharing deal structures.

Discovery Services

Cell-based Assay


Biochemical Assay




Compound Collections

Ready-to-go Assays

Phenotypic Assay

and Screening

Electrophysiology Assay

and Screening

Live the i-PRO experience


(English version)

Research and development project
“Q-RARE: Integrated technological platform for the identification and development of new drugs for the treatment of rare diseases or those with a high need for unsatisfied treatment”
Project co-financed by the European Union – National Operational Program for Enterprises and Competitiveness 2014-2020
CUP: B68I20000150005

(Italian version)

Progetto di ricercar e sviluppo
“Q-RARE: Piattaforma tecnologica integrata perl’identificazione e lo sviluppo di nuovi farmaci per il trattamento di patologie rare o ad elevato bisogno di cura insoddisfatto”
Cofinanziamento dell’Unione europea – FESR, PON Imprese e Competitività 2014-2020
CUP: B68I20000150005

Subscribe to Our Newsletter 

Follow us on